Vogue Commercial Co. Ltd Income Statement-Akums Drugs And Pharmaceuticals Ltd | Voguestock

INCOME STATEMENT

You can view the income statement for the last 5 years.
Akums Drugs & Pharmaceuticals Ltd.
( in Crs.)

ParticularsMar 26Mar 25Mar 24Mar 23Mar 22
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)PRARARARAR
FaceValue2.002.002.002.002.00
      
      
INCOME     
Revenue From Operations [Net]4359.024013.883971.213442.213581.60
Other Operating Revenues0.00104.28206.98212.6190.30
Total Operating Revenues4359.024118.164178.183654.823671.89
      
Other Income128.7352.1234.0346.1122.63
Total Revenue4487.744170.284212.213700.933694.52
      
EXPENSES     
Cost Of Materials Consumed2298.682253.612278.372028.092038.59
Purchase Of Stock-In Trade201.00181.47259.53221.79394.21
Changes In Inventories Of FG,WIP And Stock-In Trade13.84-1.6512.3424.04-87.74
Employee Benefit Expenses753.82715.82646.86590.13507.76
Finance Costs94.0734.6050.6146.2516.66
Depreciation And Amortisation Expenses154.55153.45125.64112.8194.68
Other Expenses569.65504.42858.10452.83910.80
Total Expenses4085.623841.724231.453475.933874.95
      
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax402.13328.56-19.24225.00-180.42
      
Exceptional Items-20.0216.70-26.03-74.50-12.98
Profit/Loss Before Tax382.10345.25-45.28150.50-193.40
      
Tax Expenses-Continued Operations     
Current Tax125.7081.3774.0378.1369.05
Deferred Tax0.00-79.43-103.32-27.26-6.04
Tax For Earlier Years0.00-0.46-16.771.61-5.33
Total Tax Expenses125.701.48-46.0752.4857.68
Profit/Loss After Tax And Before ExtraOrdinary Items256.40343.780.7998.02-251.08
      
Profit/Loss From Continuing Operations256.40343.780.7998.02-251.08
      
Profit/Loss For The Period256.40343.780.7998.02-251.08
      
Minority Interest-1.21-5.60-4.83-2.96-1.66
Share Of Profit/Loss Of Associates0.000.000.00-0.200.20
Consolidated Profit/Loss After MI And Associates255.19338.18-4.0494.86-252.54
      
OTHER INFORMATION     
      
EARNINGS PER SHARE     
Basic EPS (Rs.)16.6722.60-0.286.63-17.65
Diluted EPS (Rs.)16.6722.60-0.286.63-17.65
ParticularsMar 26
Months12
Source Of Info (AR = Annual Report, PR = Press Release)PR
FaceValue2.00
  
INCOME 
Revenue From Operations [Net]4359.02
Other Operating Revenues0.00
Total Operating Revenues4359.02
Other Income128.73
Total Revenue4487.74
EXPENSES 
Cost Of Materials Consumed2298.68
Purchase Of Stock-In Trade201.00
Changes In Inventories Of FG,WIP And Stock-In Trade13.84
Employee Benefit Expenses753.82
Finance Costs94.07
Depreciation And Amortisation Expenses154.55
Other Expenses569.65
Total Expenses4085.62
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax402.13
Exceptional Items-20.02
Profit/Loss Before Tax382.10
Tax Expenses-Continued Operations 
Current Tax125.70
Deferred Tax0.00
Tax For Earlier Years0.00
Total Tax Expenses125.70
Profit/Loss After Tax And Before ExtraOrdinary Items256.40
Profit/Loss From Continuing Operations256.40
Profit/Loss For The Period256.40
Minority Interest-1.21
Share Of Profit/Loss Of Associates0.00
Consolidated Profit/Loss After MI And Associates255.19
OTHER INFORMATION 
EARNINGS PER SHARE 
Basic EPS (Rs.)16.67
Diluted EPS (Rs.)16.67